₹35,000 crore for vaccination in the budget and she has assured that it could be increased if required.He said two vaccines -- Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech -- have been approved for emergency use authorisation.Besides these, work is in progress on seven vaccines.
Of the seven, three vaccines are in phase 3 clinical trial stage. Two vaccines are in phase 1 and 2 clinical trial stages and the remaining two are in advanced pre-clinical stage.He said India has received requests for vaccines from 22 countries.
These countries include Afghanistan, Algeria, Bangladesh, Bhutan, Brazil, Egypt, Kuwait, Maldives, Mauritius, Morocco, Mongolia, Myanmar, Nepal, Nicaragua, Oman,.